Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery

Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery

Terry Kim,1 Kenneth Sall,2 Edward J Holland,3 R Kim Brazzell,4 Susan Coultas,4 Preeya K Gupta1 1Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA; 2Sall Research Medical Center, Inc, Artesia, CA, USA; 3Department of Ophthalmology, Cincinnati Eye Institute, University of Cinci...

Full description

Bibliographic Details
Main Authors: Kim T, Sall K, Holland EJ, Brazzell RK, Coultas S, Gupta PK
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Clinical Ophthalmology
Subjects:
loteprednol etabonate
nanoparticle
cataract surgery
post-operative ocular inflammation
pain
Online Access:https://www.dovepress.com/safety-and-efficacy-of-twice-daily-administration-of-kpi-121-1-for-ocu-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/safety-and-efficacy-of-twice-daily-administration-of-kpi-121-1-for-ocu-peer-reviewed-article-OPTH

Similar Items